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Summary
Background: Eukaryotic cell division is driven by cyclin-
dependent kinases (CDKs). Distinct cyclin-CDK complexes
are specialized to drive different cell-cycle events, though
the molecular foundations for these specializations are only
partly understood. In budding yeast, the decision to begin a
new cell cycle is regulated by three G1 cyclins (Cln1–Cln3).
Recent studies revealed that some CDK substrates contain a
novel docking motif that is specifically recognized by Cln1
and Cln2, and not by Cln3 or later S- or M-phase cyclins, but
the responsible cyclin interface was unknown.
Results: Here, to explore the role of this new docking mecha-
nism in the cell cycle, we first show that it is conserved in a
distinct cyclin subtype (Ccn1). Then, we exploit phylogenetic
variation to identify cyclin mutations that disrupt docking.
These mutations disrupt binding to multiple substrates as
well as the ability to use docking sites to promote efficient,
multi-site phosphorylation of substrates in vitro. In cells where
the Cln2 docking function is blocked, we observed reduc-
tions in the polarized morphogenesis of daughter buds and
reduced ability to fully phosphorylate the G1/S transcriptional
repressor Whi5. Furthermore, disruption of Cln2 docking per-
turbs the coordination between cell size and division, such
that the G1/S transition is delayed.
Conclusions: The findings point to a novel substrate inter-
action interface on cyclins, with patterns of conservation and
divergence that relate to functional distinctions among cyclin
subtypes. Furthermore, this docking function helps ensure
full phosphorylation of substrates with multiple phosphoryla-
tion sites, and this contributes to punctual cell-cycle entry.
Introduction
Cyclin-dependent kinases (CDKs) are central regulators of cell
division in eukaryotes [1]. The cyclin subunit has a critical role
in triggering CDK kinase activity and plays additional regula-
tory roles by controlling subcellular localization and substrate
selection [2]. While it is possible to construct cells with only
a single cyclin-CDK complex [3], eukaryotes invariably have
several distinct forms that are specialized for particular tasks.
Generally, these cyclin-CDK forms fall into two broad classes:
those that drive DNA synthesis andmitosis (in S andMphases)
and those that control entry into a new division cycle (in
G1 phase). To understand how sequential cell-cycle events
are properly orchestrated, researchers must determine the*Correspondence: peter.pryciak@umassmed.edumolecular features of cyclin-CDK forms that impart functional
distinctions. For example, how do early forms trigger some
events without triggering others that should occur later in S
and M phases? One general class of explanation is that early
cell-cycle events may rely on cyclin-CDK complexes with low
activity but strong substrate selectivity [4, 5].
In the budding yeast S. cerevisiae, S and M phases are
driven by six B-type cyclins (Clb1–Clb6), whereas cell-cycle
entry is controlled by three G1 cyclins, Cln1–Cln3 [1, 2]. The
G1 phase constitutes a critical period in which cells determine
whether conditions are appropriate to begin dividing, and this
decision is responsive to cues such as nutrient availability, cell
size, and inhibitory signals. Ultimately, these cues affect the
function of Cln1–Cln3, which then drive the CDK phosphoryla-
tion events that commit cells to division in a step known as
‘‘Start,’’ followed by the G1-to-S transition [6–8]. Key CDK sub-
strates in this period are inhibitors of cell-cycle entry, such as
Whi5, a repressor of G1/S transcription [9, 10], as well as Cdh1
and Sic1, which prevent the expression and activity of Clb
cyclins, respectively [1]. Notably, each of these substrates
has multiple CDK phosphorylation sites [11–13], which may
place unique demands on the cyclin-CDK complex to ensure
complete phosphorylation and also dictate the threshold
CDK levels required to trigger the regulatory effect [11, 14–16].
Despite some functional overlap among Cln1–Cln3, they
have important differences [2, 4], which contribute to a
two-stage commitment process: Cln3 plays an early priming
role that initiates expression of Cln1 and Cln2, which further
enhance their own expression via a positive feedback loop,
resulting in a sharp increase in Cln1/2 activity that triggers
a decisive entry into the cell cycle [17–19]. Cln3 and Cln1/2
show distinct subcellular distributions [20, 21]. In addition,
recent studies show that Cln1/2 cyclins recognize specific
docking motifs in select CDK substrates (Figure 1A); these
‘‘LP’’ motifs (enriched in Leu and Pro residues) are not recog-
nized by either Cln3 or Clb1–Clb6, and hence, they promote
phosphorylation preferentially by Cln1/2-CDK [5, 22]. This
mechanism is analogous to recognition of RXL motifs by
S-phase cyclins such as yeast Clb5 or mammalian cyclin A
[23], but the different motifs are not cross-recognized [5, 22].
Currently, it is unknown what part of the Cln1/2 protein recog-
nizes LP motifs, or why other cyclins do not recognize them.
It is also unknown what cell-cycle events depend on Cln1/2
docking. To address these issues, in this study, we identify
and characterize a docking-defective Cln2 mutant. Our find-
ings uncover a novel substrate-docking interface that is
conserved among distinct cyclin subgroups and demonstrate
that this docking function promotesmulti-site phosphorylation
of substrates and punctual entry into the cell cycle.
Results
Strategic Framework for Localizing the Docking Interface
in Cln2
Before screening for a docking-defective Cln2 mutant, we
needed a strategy to distinguish specific defects in docking
from more general defects in CDK activation. Our solution
was tocompare aCDKsubstrate harboring anative LPdocking
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Figure 1. Sequence Constraints and Evolutionary Conservation of Docking Function
(A) Interaction of Cln1/2 with ‘‘LP’’ docking sites promotes CDK substrate phosphorylation.
(B) Expected phenotype of a docking-defective Cln1/2 mutant. Defects in docking versus CDK activity can be discerned by comparing substrates with a
docking site versus a leucine zipper.
(C) Cln3 exemplifies non-docking behavior. Cyclins (with truncated C termini) were expressed as fusions to GST plus a half leucine zipper (GST-[lz]), along
with a Ste5-derived substrate harboring either the partner half leucine zipper or an LP docking site (see Experimental Procedures and Figure S1A). Reduced
mobility indicates phosphorylation.
(D)Mutations in theHP region of Cln2 (hpm1, 3; see Figure S1B) do not confer specific docking defects but rather amild general reduction in phosphorylation
activity.
(E) Full-length Cln2 (1–545) and truncated forms were tested for substrate phosphorylation (as in C and D). Endpoints are shown relative to regulatory
phosphorylation sites (P sites) and tandem cyclin box folds (CBF1, 2) predicted for Cln2 (see Figure S1C). Lower abundance for 1–352 was reproducible.
(F) Conservation of LP docking in Cln1/2 and Ccn1 cyclins. Top: phylogenetic tree of six yeasts and their G1 cyclins. The Ccn1 group is related but distinct
fromCln3 and Cln1/2 groups. Bottom: cyclins from different yeasts were expressed in S. cerevisiae as GST-(lz) fusions to test substrate phosphorylation. All
cyclins had truncated C termini; see Figure S1C. WGD, whole genome duplication.
317site with one that instead uses a leucine zipper to promote cy-
clin-substrate interaction, expecting that the desired class of
mutant would only show defects with the former (Figure 1B).
Indeed, this predicted behavior is exemplified by Cln3, which
doesnot recognizeLPdocking sites (Figure 1C). Hence, in prin-
ciple, we sought a Cln2 mutant that behaves more like Cln3.
Because S-phase cyclins recognize RXL motifs via a hydro-
phobic patch (HP) on their surface, we wondered whether
the different makeup of this region in Cln1/2 cyclins allowed
recognition of LP rather than RXL motifs. However, mutations
in this part of Cln2 did not confer a specific defect in LP dock-
ing, and instead, they caused a general mild reduction in all ac-
tivity, including auto-phosphorylation of the Cln2 C terminus
(Figure 1D). Hence, we concluded that LP recognition is
encoded elsewhere on Cln2. To constrain the candidate se-
quences, we tested truncations of the Cln2 C terminus and
found that roughly one-third of the protein was dispensablefor LP recognition, whereas truncations that perturb the pre-
dicted globular cyclin box fold domains (CBF1, 2) eliminated
all activity (Figure 1E). Thus, all positions within the roughly
370-residue core of Cln2 remained candidates.
To evaluate which residues might contribute to docking,
we devised a strategy to exploit natural sequence variation.
Namely, by expressing G1 cyclins from other yeasts in
S. cerevisiae, we found that recognition of LP docking sites
was conserved in other Cln1/2 members and lacking among
Cln3 members (Figure 1F). Moreover, we tested a distinct
class of G1 cyclins, the Ccn1 group, which is absent from
S. cerevisiae but present in other yeasts (Figure 1F, top).
Remarkably, Ccn1 members were proficient at using an LP
docking motif to drive substrate phosphorylation (Figure 1F).
This revealed that LP docking exists for a class of cyclins other
than Cln1/2 and offered a way to further constrain the possible
residues involved in docking.
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Figure 2. Identification of a Docking-Defective Cln2 Mutant
(A) Twelve regions of Cln2 were mutated, emphasizing residues conserved
in Cln1/2 and Ccn1 groups, but not in Cln3 (see Figures S2A and S2B). One
example (m4/lpd) is illustrated by the sequence alignment, with mutated
positions marked by asterisks.
(B) Cln2mutantswere expressed asGST-(lz) fusions to test phosphorylation
in vivo of substrates with either of two LP docking sites (from Ste5 or Ste20)
or the leucine zipper. See also Figure S2C.
(C) Left: the lpd mutation was tested in four different cyclins (two Cln1/2
and two Ccn1) for effects on docking-dependent phosphorylation. Right:
analysis of single mutations at each of the three residues mutated in the
lpd mutant.
318Identification of a Docking-Defective Cln2 Mutant
Sequence alignments with multiple members of the Cln1/2,
Cln3, and Ccn1 groups revealed that there were many posi-
tions where Ccn1 and Cln3 residues were identical (or nearlyso), and hence, we excluded these from consideration as
key residues for LP docking. Then, we scrutinized positions
that correlated with docking ability (i.e., similar in Cln1/2 and
Ccn1, but different in Cln3). Based on these considerations,
12 Cln2 mutants were designed (Figures 2A and S2).
These mutants were tested for phosphorylation of sub-
strates with two distinct LP sites or the control leucine zipper
(Figures 2B and S2C); we also monitored auto-phosphoryla-
tion of the Cln2 C terminus. Several mutants (m1, m2, m5,
m6, m9) showed non-specific reduction in phosphorylation
of all substrates, including the leucine zipper control (note
the drop in the uppermost bands and the increased propor-
tion of the bottom band), while two mutants (m8, m10)
had no detectable activity and no auto-phosphorylation. By
contrast, one mutant, Cln2-m4, displayed the desired pheno-
type, as it showed a specific defect with LP-containing sub-
strates but normal phosphorylation of the control substrate
(Figure 2B). Based on these and additional findings described
below, we hereafter designate this mutant as ‘‘lpd’’ (for ‘‘LP
docking’’). To explore the generality of this phenotype, we
compared the analogous mutation in two Cln1/2 members
and two Ccn1 members (Figure 2C, left). Each showed the
same behavior, in which the lpd mutant was defective at us-
ing a native LP dock but fully competent to use the leucine
zipper. We also tested each of the single residue changes
in the original Cln2-lpd triple mutant and found that one of
them, L112A, was largely responsible for the defect (Fig-
ure 2C, right); however, this single mutant was not as defec-
tive as the lpd triple mutant, and we observed mild defects
with each of the other two (R109A and R113A), and hence,
we used the original lpd triple mutant for further analyses.
Collectively, these findings argue that the lpd mutation dis-
rupts a region of the cyclin with a specific role in utilizing
LP docking sites.
Cln2 Docking Function Is Required for Interaction with
Multiple Substrates
To verify that Cln2-lpd was defective at docking interactions,
we assayed substrate binding. First, we compared several of
the initial Cln2 mutants, expressed as glutathione-S-trans-
ferase (GST) fusions, for their ability to co-precipitate Ste5, a
substrate with an LP motif [22]. As predicted for a docking
mutant, Cln2-lpd showed reduced binding to Ste5 but normal
binding to its partner CDK molecule, Cdc28 (Figure 3A). The
specific nature of this phenotype was reinforced by compari-
son to other mutants: (1) Cln2-m3 showed no binding defects,
consistent with its full activity in phosphorylation assays; (2)
Cln2-m5 showed reduced binding to both Ste5 and Cdc28,
suggesting a non-specific defect that agrees with its reduced
activity against all substrates; and (3) Cln2-m8 and Cln2-m10
were defective at binding Cdc28 but bound Ste5 normally,
which agrees with their inactivity in phosphorylation assays
and shows that binding Cdc28 is not required to bind
substrates.
We also conducted reciprocal assays in which GST-sub-
strate fusions were used to co-precipitate V5-tagged Cln2
(Figures 3B and S3A) and found that Cln2-lpd showed sub-
stantially reduced binding to most substrates tested (i.e.,
Ste20, Ste5, Sic1, Whi5, Rga1, Tus1). An exception was Srl3,
which binds Cln2 especially strongly; this might indicate a
distinct mode of binding (e.g., involving the CDK) or that the
reduction in binding is too mild to register in this assay. As a
further control, we tested binding to Grr1, an F-box protein
that promotes Cln2 ubiquitination; this binding was unaffected
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Figure 3. Docking-Defective Cln2 Mutant Shows Reduced Binding to Multiple Partners
(A) Cells co-expressed a galactose-inducible GST cyclin (or vector) with V5-tagged Ste5. After galactose induction, GST fusions and co-bound proteinswere
captured with glutathione-Sepharose. Bound and input proteins were analyzed by immunoblots.
(B) Cells expressed V5-tagged Cln2 (WT or lpd) and galactose-inducible GST fusions to full-length proteins or N-terminal fragments. Ste5* is a hybrid
fragment [22, 24] in which the Cln2 docking site in the Ste20 N terminus is replaced with one from Ste5. Grr1DF lacks its F box to prevent it from driving
degradation of Cln2 [25]. See also Figure S3.
319by the lpd mutation (Figure 3B), consistent with the fact that
Grr1 recognizes the phosphorylated C terminus of Cln2 rather
than the globular CBF domains [25, 26]. Finally, we also as-
sayed substrate binding by one of the Ccn1 family members
(Figure S3B). This cyclin bound only a subset of the substrates
that bind Cln2, indicating some divergence in docking motif
recognition (to be pursued separately), but eachwas disrupted
by the Ccn1-lpd mutation.
In Vitro Kinase Assays Confirm a Specific Defect in
Docking Function
To probe the biochemical phenotypes in vitro, we purified
wild-type (WT) and lpd versions of the Cln2-Cdc28 complex
from yeast cells (Figure S4A). Cln2-lpd co-purified with normal
amounts of Cdc28, and, when using histone H1 as a generic
substrate, WT and lpd complexes showed indistinguishable
kinase activity. In contrast, with other substrates, the Cln2-
lpd complex showed defects that indicated a specific failure
in LP docking function (Figures 4A and S4B). Namely, for
several substrates (Sic1, Sic1DC, Whi5, Stb1), the activity of
the Cln2-lpd complex was reduced to a level comparable to
that seen when the WT complex was inhibited with a compet-
itor LP peptide (Figure 4A). The competitor peptide had negli-
gible effect on the Cln2-lpd complex, indicating that its
reduced activity specifically reflects an inability to recognize
the LP docking site to enhance phosphorylation. Similarly,
when the LP docking site on Sic1 was mutated (vllpp), this
reduced phosphorylation by theWT complex but did not affect
the lpd complex (Figures 4A and S4B).
To further assess the Cln2-lpd defect, we analyzed the prod-
ucts of these kinase reactions on Phos-tag gels, which can
resolve substrate isoforms differing in the number of phos-
phates added and do so especially clearly for the substrate
Sic1 [14, 15]. Notably, the Cln2-lpd complex could not
generate the most highly phosphorylated products and
instead yielded products modified on few sites, similar to
when the LP site in the substrate was mutated (vllpp; Figures
4B and S4C). Other substrates were also less highly modified
(Figure S4B), though resolution of the intermediates was
poorer. Collectively, these in vitro findings show that the
Cln2-lpd mutant has a specific defect in utilizing LP docking
sites to drive extensive, multi-site phosphorylation.Cln2-Substrate Docking Helps Coordinate the G1/S
Transition with Cell Size
To assess how docking contributes to the cellular functions of
Cln2, we first asked whether Cln2-lpd supports cell division
when expressed from its native promoter. Indeed, it permitted
growth when provided as the only G1 cyclin (Figure S5A), as
well as under conditions where CLN3 was not sufficient (i.e.,
cln1D cln2D pcl1D pcl2D; Figure S5B). These results confirm
that Cln2-lpd remains generally active and indicate that dock-
ing is not the only function that discriminates Cln1/2 fromCln3.
Because G1 phase is a period of growth before division, de-
fects in the control of cell-cycle entry can affect cell size [7, 27].
When we measured cell volumes in asynchronous cultures
(using cln1D strains to eliminate redundancy between Cln1
and Cln2), cln2-lpd cultures were shifted toward mildly larger
cells (Figure 5A, top), consistent with a known role for Cln1/2
in setting critical size [19, 28, 29]. Remarkably, this difference
was amplified in cells lacking the CDK inhibitor protein Far1
(Figures 5A and S5C). We were primed to consider such an ef-
fect by our recent finding that Far1 competitively interferes
with Cln2-substrate docking [24]; this raised the possibility
that mutations in the docking interface of Cln2 could impair in-
teractions with both substrates and Far1, so that the resulting
defects in positive functions of Cln2 are partly counteracted by
reduced inhibition from Far1 (see Discussion). Hence, to avoid
differential inhibition, further analysis used far1D strains.
In the microscope, mother cells and unbudded cells in
cln2-lpd cultures had significantly larger diameters compared
to WT (Figures 5B and S5D), suggesting that they did not
begin dividing until reaching a larger size. Indeed, when G1
cells were isolated by centrifugal elutriation (Figure 5C), the
cln2-lpd cells delayed budding and DNA synthesis until they
reached a volume roughly one-third greater than WT (i.e.,
w40 versus 30 fL). Thus, disruption of Cln2 docking skews
the calibration between cell size and cell-cycle entry. To
pinpoint the defect, we conducted time-lapse microscopy
with fluorescent forms of two key G1/S regulators, the
transcriptional repressor Whi5 and the CDK inhibitor Sic1. In
cln2-lpd cells, nuclear exit of Whi5 was delayed, whereas
Sic1 degradation and budding occurred with relatively normal
timing thereafter (Figure 5D). Thus, the predominant effect of
Cln2-lpd is to delay Start (Figure 5E), which coincides with
AB
Figure 4. Docking Promotes Multi-site Phosphorylation of Substrates
In Vitro
(A) Cln2-Cdc28 complexes containing either WT or lpd Cln2 were purified
from yeast cells and assayed for substrate phosphorylation in vitro, both
with and without a competitor LP peptide. Sic1DC is residues 1–215, and
vllpp denotes mutation of its LP docking site. Top: total 32P incorporation
into substrates. Bottom: 32P incorporation was quantified from two reaction
times (8 and 16 min.) and then normalized to the results with histone H1 for
each of the four conditions; bars represent the mean 6 range. See also
Figure S4B.
(B) The indicated Sic1 substrates were phosphorylated by Cln2-Cdc28 (WT
or lpd), and the products were separated on a Phos-tag gel to assess the
multiplicity of phosphorylation. See also Figures S4B and S4C.
320Whi5 exit and the onset of G1/S transcription [19, 30]. This
delay did not cause an accumulation of G1 cells in asynchro-
nous cultures (Figure S5E), likely because cells that bud at a
larger size also produce larger daughters (i.e., with a larger
birth size), and hence, the time from birth to budding remains
comparable. Size is also regulated by nutrients such as carbon
source [7, 27], but the cln2-lpd cells still shifted to smaller
sizes in poor carbon media and were always larger than WTregardless of nutrients (Figure S5F). Therefore, nutrient regula-
tion remains intact, but the eventual execution of Start is
delayed in cln2-lpd cells.
Docking Promotes Whi5 Phosphorylation and Bud
Polarization
To analyze Whi5 phosphorylation in vivo, we first eliminated
delays in achieving critical cell size by synchronizing cells
with a prolonged G1 arrest in mating pheromone. Cells ar-
rested in G1 continue to grow [31], so upon release, can begin
cell-cycle entry without further growth delay [32], similar to
large mother cells [33]. To further equalize initial conditions,
we used cells with a separate PMET3-CLN2 construct [19, 28]
that was expressed only during initial propagation and then
repressed during the experiment.
Using these conditions, we monitored Whi5 gel mobility
(Figure 6A), which reflects CDK phosphorylation [9, 10, 12].
V5-tagged Whi5 was resolved into three species: one in G1 ar-
rested cells, plus two higher forms that appeared after release
(Figure 6A, i and ii). InCLN2-wt cells, the highest formeventually
became the predominant species, whereas this never occurred
incln2-lpdcells, and instead, themiddle formwaspredominant.
This pattern suggests that Cln2-lpd cannot drive Whi5
phosphorylation as extensively as WT, in agreement with the
in vitro assays. GFP-tagged Whi5 was resolved into only two
species (Figure 6A, iii), but again we observed less of the top
form in cln2-lpd cells. This reduced phosphorylation of Whi5
was associated with mildly reduced G1/S transcription (Fig-
ure 6B) and budding (Figure S6A), whereas DNA synthesis
was unaffected (Figure S6A), consistent with Cln1/2 serving a
moreunique role inbudemergence,whereasClb5/6 expression
drives DNA synthesis [28, 32, 34]. Strikingly, in the absence of
Cln2 (i.e., empty vector), phosphorylation of Whi5 by Cln3 was
barely (if at all) detectable (Figure 6A, ii and iii), despite prior sug-
gestions thatCln3 triggers its initial inactivation [10, 19]. This im-
plies that Cln3-CDK phosphorylates Whi5 at most only weakly,
whereas Cln1/2-CDK drives more complete phosphorylation
(see Discussion). Altogether, the findings indicate that Cln2-
lpd isprimarilydeficientatdriving fullmodificationofsubstrates.
Interestingly, in these synchronous cultures, the Cln2-lpd
protein was initially expressed on schedule but then persisted
long after the WT protein declined (Figure 6A, iii), suggesting
that it might have a reduced turnover rate. Indeed, in a cyclo-
heximide chase assay, the half-life was roughly doubled for
the mutant protein (Figure 6C). Hence, Cln2 turnover might
involve docking with specific partner proteins (see Discus-
sion). This stabilization is also noteworthy because the
increased protein levels or duration in the mutant might
partially counteract its defects.
Finally, we analyzed how docking contributes to cell polari-
zation. Early in the cell cycle, Cln1 and Cln2 promote highly
polarized apical growth of new buds, which then shifts to an
isotropic pattern as Cln1/2 levels decline and Clb1-6 cyclins
take their place [35]. If Cln2 is expressed continuously from a
foreign promoter (e.g., PGAL1), it can drive incessant apical
growth and hyperpolarized buds [35]. We found that this hy-
perpolarized growth was greatly diminished for the docking
mutant, Cln2-lpd (Figure 6D). Furthermore, the hyperpolarized
phenotype was also observed upon expression of other mem-
bers of the Cln1/2 and Ccn1 subgroups (Figures 6E and S6B),
and in each case, this was disrupted by the lpdmutation. Thus,
docking helps each of these cyclins drive directionally persis-
tent growth, which may be of particular importance in fungi
that form hyphal filaments.
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Figure 5. Cln2-lpd Alters the Critical Cell Size for
Cell-Cycle Entry
(A) Cell volume is increased in cln2-lpd strains.
Note that all strains are cln1D. Solid and dashed
lines show mean 6 SEM (n = 6, in YPD). See
also Figure S5C.
(B) Increased diameters of mother and unbudded
cells in cln2-lpd strains compared to CLN2-wt, in
far1D cln1D background. Cells were grown in SC
with raffinose. Lines denote mean6 SD. See also
Figure S5D.
(C) Small G1 daughter cells (in far1D cln1D back-
ground), grown in SCwith raffinose, were isolated
by centrifugal elutriation and inoculated in fresh
YPD medium (note that cln2-lpd cells were born
larger than WT cells); samples were collected at
15-min intervals to assay cell volume, budding,
and DNA replication. For each strain, we assayed
two elutriator fractions (denoted by open and
closed symbols) with distinct starting median
cell volumes (17 and 23 fL for CLN2-wt, or 27
and 30 fL for cln2-lpd) to confirm that the pheno-
types relate to size rather than incubation time.
(D) Time-lapse microscopy was used to monitor
the diameter of cells at the times of Whi5 nuclear
exit and bud emergence (left), as well as the time
intervals separating Whi5 exit from Sic1 degrada-
tion and budding (right). Only the first G1 of newly
born daughter cells was monitored. Lines show
mean 6 SD.
(E) Summary of phenotypes. In cln2-lpd cells,
Whi5 nuclear exit is delayed, and Start occurs at
a larger cell size. After the delayed Start, subse-
quent events (DNA replication, bud emergence)
occur with relatively normal timing.
321Discussion
Wehave identified amutant formof the yeast cyclin Cln2 that is
deficient in recognition of LP docking sites on CDK substrates.
The detection of key residues was aided by the discovery that
LP docking is conserved in both Cln1/2 and Ccn1 groups, and
this conservation attests to a selectively advantageous func-
tion. Cln3 and Cln1/2 likely diverged from each other after
they split from the Ccn1 group (N. Buchler, personal communi-
cation), implying that LP docking existed in the prior common
ancestor but was then lost in Cln3. Indeed, most non-yeast
fungi (dikarya) harbor only one G1 cyclin, and initial studies
suggest that they can recognize LP motifs (S.B. and P.M.P.,
unpublished data). Still, LP docking may not be identical
in each case, as Ccn1 bound only some partners of Cln1/2
(Figure 3D). Thus, evolution of distinct cyclin subtypes likely
included both loss of docking and divergence of motif
preferences.
A structural comparison (Figures 7A and 7B) suggests that
the region required for LP docking is close but separated
from the HP region that allows S-phase cyclins to bind RXL
motifs [37–39]. The lpd residues begin at a ridge bordering
the HP cleft and then proceed along the edge of an adjacent
plateau. The non-polar Leu112 residue that is most critical in
Cln2 is predicted to be solvent exposed and thus is well suitedto interact favorably with Leu/Pro-rich
LP motifs. Interestingly, although RXL
peptides from CDK substrates do not
encroach upon the lpd plateau [40, 41],
the inhibitor protein p27, which bindscyclin A-CDK2 over a broad interface [42], doesmake contacts
in this region as it traverses from cyclin to CDK (Figure 7A).
Hence, LP docking and CDK inhibition could be evolutionarily
related.
In vitro, the docking function of Cln2 was required for multi-
site phosphorylation of substrates, which involves processive
catalysis and the Cks1 subunit of the cyclin-CDK-Cks1 com-
plex [15, 43]. Thus, in vivo, events that require extensive sub-
strate phosphorylation may be especially dependent on dock-
ing, and this couldunderlie some functional distinctions among
G1 cyclins. For example, although Cln3 is thought to initiate
inactivation of Whi5, Cln1/2 substantially accelerates its chro-
matin dissociation and nuclear exit [10, 19]. Likewise, we saw
that Cln3 is not as proficient as Cln2 at driving extensive Whi5
modification in vivo, and the superior activity of Cln2 depends,
at least in part, ondocking.Whi5might bephosphorylated via a
two-stage relay, first by Cln3 and then more completely by
Cln1/2; this would be analogous to Rb phosphorylation by cy-
clins D and E in animal cells [44] and to the sequential phos-
phorylation of Sic1 by Cln1/2 and Clb5 in yeast [14, 16]. Yet,
although our results clearly reveal phosphorylation of Whi5
by Cln1/2, there is scant (if any) evidence that Cln3 can do so,
and hence, this remains an important issue for future studies.
Although substrate docking by Cln2 helps cells initiate divi-
sion at the proper size, Cln1/2 are not expected to be involved
A B
C
D E
Figure 6. Whi5 Phosphorylation and Bud Polarization Depend on Cln2 Docking
(A) CLN3 cln1D cln2D PMET3-CLN2 and cln3D cln1D cln2D PMET3-CLN2 cells harbored a CLN2 plasmid (WT or lpd; native promoter) or empty vector. Cells
were arrested in G1 phase with a factor (plus methionine to repress PMET3-CLN2) and then released; aliquots were harvested at times shown. Whi5 phos-
phorylation was monitored by immunoblotting for Whi5-V5 (i, ii) or Whi5-GFP (iii); Cln2-V5 levels and a loading control (G6PDH) are shown for set (iii).
(B) mRNA levels were measured, in the cln3D background, using conditions as in panel (A). Graphs plot mean6 SEM (n = 5), and asterisks indicate p < 0.05
(t test) for WT versus lpd.
(C) The Cln2-lpd protein shows reduced turnover. Cells harboring aCLN2-V5 plasmid (WT or lpd; as in panel A, iii; growing in +Metmedium)were treatedwith
50 mg/mL cycloheximide (CHX). Cln2-V5 and G6PDH levels were measured at times indicated. The graph plots the fraction of protein remaining (mean6 SD;
n = 4) with exponential trend lines; half-lives (t1/2) were calculated by fitting to an exponential decay.
(D) Cells harboring a PGAL1-CLN2 plasmid (WT or lpd) were induced with galactose for 1.5 or 3 hr. Images are from 1.5 hr. Plots show individual bud lengths
with mean 6 SD (n > 150); p = 10229 (1.5 hr) or p = 10233 (3 hr) by two-tailed t test.
(E) Cells harboring PGAL1-CLN2 or PGAL1-CCN1 plasmids (as in Figure 2C) were induced with galactose for 3.5 hr. Plots show bud lengths with mean 6 SD
(n > 50); for all pairwise comparisons of WT versus lpd, p < 1024 (two-tailed t test). See also Figure S6B.
322in the size sensing mechanism per se, but rather in the robust
execution of molecular events that drive cell-cycle entry once
the sensing mechanism is satisfied [7, 27]. The commitment
point at Start comprises a brief interval in which Cln1/2-CDK
activity rapidly accumulates (Figure 7C), and many key regula-
tors of the G1/S transition are proteins with multiple CDK sites,
including not only Whi5 but also Sic1 and Cdh1 [11, 13].
Accordingly, the docking function of Cln1/2 likely contributes
to a rapid and decisive transition by ensuring that full phos-
phorylation of substrates occurs promptly once cyclins arise.
The need for docking might be reduced in G1 arrest and
release experiments because cells grow beyond the critical
size by the time of release, and this can alter the CDK threshold
required to pass Start [32, 33].
The contribution of LP docking to polarized morphogenesis
likely relates to Cln2 substrates involved in cell polarization,
such as regulators of Rho GTPases (reviewed in [45, 46]),some examples of which (i.e., Rga1, Tus1) showed reduced
binding to Cln2-lpd. Relatedly, G1 cyclins drive persistent hy-
phal tip growth in filamentous fungi [46–49]. Substrate docking
by Cln1/2 and Ccn1 could help maintain high levels of phos-
phorylation in a local region or even co-localize the cyclin
with substrates at sites of polarized growth.
In addition to its positive role, the docking interface on Cln2
might promote regulation by antagonists (Figure 7D). First,
the Cln2-lpd protein showed reduced turnover, suggesting
that the docking interface might engage a degradation factor,
such as Cdc48 [50]. Second, enhanced phenotypic differences
between WT and cln2-lpd alleles in far1D cells suggest that
Far1 might inhibit Cln2-wt and Cln2-lpd differentially. Far1
blocks Cln2-substrate docking [24], perhaps by engaging
the docking interface. Indeed, in a recently developed in vitro
assay for Far1 inhibition (E.V. and M.L., unpublished data),
the Cln2-lpd mutation increased the Ki of Far1 by roughly
A C
B
D
Figure 7. Docking Interfaces and Models
(A) Structures of a mammalian cyclin A-CDK2 complex, with and without the inhibitor protein p27 (PDB IDs: 1H26, 1JSU), compared to models for
S. cerevisiaeCln2 andK. waltiiCcn1 generated by the I-TASSER algorithm [36]. The HP (yellow) and residues altered in the lpdmutants (red) are highlighted.
(B) Close-up of the boundary between HP and lpd regions in the predicted models, with mutated residues labeled.
(C) General model. Cln3-CDK initiates expression of CLN1/2 (and then Cln1/2-CDK further increase this expression). As Cln1/2-CDK activity accumulates,
the efficiency with which it fully phosphorylates multi-site substrates may affect the duration of Start and the G1/S transition.
(D) Disruption of Cln2 docking may simultaneously disrupt both positive output and negative regulation. See text for discussion.
32310-fold. Competition among substrates and regulators for a
common interface may provide a simple mechanism to inte-
grate multiple signals, and there are precedents in cyclin-
CDK complexes [37, 41, 42] and MAP kinases [51].
In conclusion, our findings uncover a novel substrate-dock-
ing interface, conserved among distinct G1 cyclin subgroups,
that contributes to efficient, multi-site phosphorylation of CDK
substrates and to the punctual entry into the cell cycle. Future
studies of LP docking could shed light on cyclin evolution and
the role of CDKs in polarized growth, in addition to illuminating
how robust CDK phosphorylation influences cell-to-cell vari-
ability of Start [29, 33] and the coherence of distinct events
at the G1/S transition [19].
Experimental Procedures
Yeast Methods
Standard procedures were used for growth and genetic manipulation
of yeast [52, 53]. Cells were grown at 30C in yeast extract with peptone
medium with 2% glucose (YPD) or galactose (YPGal) or in synthetic (SC)
medium with 2% glucose or raffinose. Strains and plasmids are listed in
the Supplemental Information.
In Vivo Phosphorylation Assays
As described previously [22, 24], cells harboring PGAL1-GST-cyclin con-
structs and HA-tagged CDK substrates were induced with 2% galactose
(for 2.5 hr) to drive cyclin expression; as before [24], most cyclins were
truncated to remove destabilizing C termini (see Figure S1C), thus allowing
comparable expression. All substrates were based on the Ste5 N terminus
(1–260), with or without docking sites: (1) the ‘‘LP dock’’ was from Ste5(261–315 or 261–337), except where noted as being from Ste20 (80–115);
(2) ‘‘no dock’’ substrates had either no added sequence or a mutated Ste5
LP motif; and (3) leucine zipper substrates had the E34(N) sequence (see
Figure S1A). Substrate phosphorylation was assessed by SDS-PAGE and
immunoblotting of whole-cell lysates (see Supplemental Information).
Protein-Binding Assays
GST co-precipitation assays were performed as described [24]. Briefly,
10-ml cultureswere treatedwith 2%galactose (1.5 hr) to expressGST fusion
proteins. Extracts were prepared by glass bead lysis, and GST fusions and
co-bound proteins were collected on glutathione-sepharose.
In Vitro Kinase Assays
Cln2-Cdc28-Cks1 complexes were purified from yeast, and substrates
(except histone H1) were purified from bacteria. Reactions contained kinase
and substrate, with or without competitor LP peptide. For detailedmethods,
see the Supplemental Information.
Synchronous Cultures
Small G1 cells were purified by centrifugal elutriation as described previ-
ously [54]. Initial cultures were grown in SC/raffinose, and elutriated cells
were resuspended in YPD. For G1 arrest and release, PMET3-CLN2 cells
harboringCLN2 plasmids were arrested in +Metmedium containing a factor
and released in +Met medium without a factor; see Supplemental Informa-
tion for details.
Flow Cytometry, Budding, and Cell-Size Measurements
As described previously [55], DNA content wasmeasured by flow cytometry
using Sytox Green, and budding status was assayed using formaldehyde-
fixed cells (200 cells were counted per condition). Cell volume was
measured using a Beckman Coulter Multisizer 3 (Beckman Coulter). Cell di-
ameters andbud lengthsweremeasuredmicroscopically (seeSupplemental
Information).
324mRNA Analysis
RNA was prepared as described previously [55]. Synthesis of cDNA and
quantitative real-time PCRwas performed as described in the Supplemental
Information.
Time-Lapse Microscopy
Cells in SC with glucose medium were entrapped in a CellASIC microfluidic
device as described [30]. Images were acquired every 3 min, and multiple
fields were followed simultaneously. Fluorescence data were analyzed via
automated algorithms [56] to determine midpoint times of Whi5-mCherry
nuclear exit and Sic1-GFP degradation. Phase-contrast images were in-
spected manually to determine the time of bud emergence and the cell
diameters at Whi5 exit and budding onset.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cub.2014.11.069.
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